Evidence map›Paper›PMID 20479472›Full record

ReviewThe Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry2010

Is epilepsy a preventable disorder? New evidence from animal models.

Kathryn A Giblin, Hal Blumenfeld

Open access · greenAbstract readReview
In one paragraph

Review in The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Neuroimaging the epileptogenic process.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2014
    Review
  8. Article
  9. Review
  10. Article
  11. Epilepsy and epileptic syndrome.Advances in experimental medicine and biology · 2012
    Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kathryn A GiblinDepartment of Neurology, Yale University School of Medicine, New Haven, CT 06520-8018, USA.
Hal Blumenfeld
Yale University · US

Funding

Functional Neuroimaging in Childhood Absence EpilepsyR01NS055829 · NINDS · YALE UNIVERSITY · PI BLUMENFELD, HAL · 2006 to 2016
$3.2M
Preventing spike-wave epileptogenesis: critical periods & neuroimaging biomarkersR01NS049307 · NINDS · YALE UNIVERSITY · PI BLUMENFELD, HAL · 2004 to 2010
$2.3M
NINDS NIH HHS NS049307NINDS NIH HHS R01 NS049307NINDS NIH HHS R01 NS055829
6 · The paper itself

Abstract

Epilepsy accounts for 0.5% of the global burden of disease, and primary prevention of epilepsy represents one of the three 2007 NINDS Epilepsy Research Benchmarks. In the past decade, efforts to understand and intervene in the process of epileptogenesis have yielded fruitful preventative strategies in animal models.This article reviews the current understanding of epileptogenesis, introduces the concept of a "critical period" for epileptogenesis, and examines strategies for epilepsy prevention in animal models of both acquired and genetic epilepsies. We discuss specific animal models, which may yield important insights into epilepsy prevention including kindling, poststatus epilepticus, prolonged febrile seizures, traumatic brain injury, hypoxia, the tuberous sclerosis mouse model, and the WAG/Rij rat model of primary generalized epilepsy. Hopefully, further investigation of antiepileptogenesis in animal models will soon enable human therapeutic trials to be initiated, leading to long-term epilepsy prevention and improved patient quality of life.

Indexed as

Disease Models, AnimalEvidence-Based MedicineAnimalsEpilepsyGenetic Predisposition to DiseaseHumansNeural Conduction

Identifiers

PMID20479472
PMCPMC2911489
OpenAlexW2083185484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.